| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transporter activity | GABRD CACNA1A ABCC4 ATG9B GLTP SLC38A4 PEX13 GRIA1 SLC43A3 XKR4 TTPA SLC1A3 ABCA9 MFSD12 RYR2 SLC4A1 ITPR1 SLC7A4 ZACN GJB5 CLCN1 KCNC1 NALCN KCNC3 TRPM3 SLC19A1 SLCO2A1 BEST4 SLC35D3 NPC1L1 SCN5A PKD1 ABCB11 CACNA1I CACNA1G SLC4A4 CNGB1 SLC23A2 DISP1 SLC35A5 | 1.01e-15 | 1289 | 143 | 40 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | GABRD CACNA1A ABCC4 SLC38A4 PEX13 GRIA1 SLC43A3 SLC1A3 ABCA9 MFSD12 RYR2 SLC4A1 ITPR1 SLC7A4 ZACN GJB5 CLCN1 KCNC1 NALCN KCNC3 TRPM3 SLC19A1 SLCO2A1 BEST4 SLC35D3 SCN5A PKD1 ABCB11 CACNA1I CACNA1G SLC4A4 CNGB1 SLC23A2 DISP1 SLC35A5 | 3.55e-13 | 1180 | 143 | 35 | GO:0022857 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | GABRD CACNA1A SLC38A4 GRIA1 SLC1A3 RYR2 SLC4A1 ITPR1 ZACN CLCN1 KCNC1 NALCN KCNC3 TRPM3 SLC19A1 BEST4 SCN5A PKD1 CACNA1I CACNA1G SLC4A4 CNGB1 SLC23A2 | 1.07e-08 | 793 | 143 | 23 | GO:0015075 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR5B3 OR5M10 NPY6R NPY5R OR5M1 OR2B2 GPR34 OR10P1 ADGRV1 SUCNR1 GRM4 GRM8 OR8U9 ADGRG7 OR52I1 TAS2R16 OR5J2 ADRB2 ACKR3 OR52E5 TAS2R45 OR52A1 CX3CR1 HRH3 | 1.75e-08 | 884 | 143 | 24 | GO:0004930 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | GABRD CACNA1A ABCC4 SLC38A4 GRIA1 SLC1A3 RYR2 SLC4A1 ITPR1 CLCN1 KCNC1 NALCN KCNC3 TRPM3 BEST4 SCN5A PKD1 CACNA1I CACNA1G SLC4A4 CNGB1 SLC23A2 | 2.29e-08 | 758 | 143 | 22 | GO:0015318 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GABRD IL10RA OR5B3 OR5M10 NPY6R NPY5R OR5M1 OR2B2 GPR34 OR10P1 GRIA1 ADGRV1 SUCNR1 GRM4 GRM8 OR8U9 ADGRG7 OR52I1 TAS2R16 ZACN OR5J2 ADRB2 ACKR3 PKD1 OR52E5 TAS2R45 OSMR OR52A1 CX3CR1 HRH3 | 2.30e-08 | 1353 | 143 | 30 | GO:0004888 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | ABCC4 SLC38A4 GRIA1 SLC43A3 SLC1A3 MFSD12 SLC4A1 SLC19A1 SLCO2A1 BEST4 SLC35D3 ABCB11 SLC4A4 SLC23A2 | 2.57e-08 | 293 | 143 | 14 | GO:0008514 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | GABRD CACNA1A GRIA1 RYR2 ITPR1 ZACN CLCN1 KCNC1 NALCN KCNC3 TRPM3 BEST4 SCN5A PKD1 CACNA1I CACNA1G CNGB1 | 3.33e-08 | 459 | 143 | 17 | GO:0005216 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1A SLC38A4 GRIA1 SLC1A3 RYR2 ITPR1 KCNC1 NALCN KCNC3 TRPM3 SCN5A PKD1 CACNA1I CACNA1G SLC4A4 CNGB1 SLC23A2 | 4.02e-08 | 465 | 143 | 17 | GO:0046873 |
| GeneOntologyMolecularFunction | channel activity | GABRD CACNA1A GRIA1 RYR2 ITPR1 ZACN GJB5 CLCN1 KCNC1 NALCN KCNC3 TRPM3 BEST4 SCN5A PKD1 CACNA1I CACNA1G CNGB1 | 4.13e-08 | 525 | 143 | 18 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | GABRD CACNA1A GRIA1 RYR2 ITPR1 ZACN GJB5 CLCN1 KCNC1 NALCN KCNC3 TRPM3 BEST4 SCN5A PKD1 CACNA1I CACNA1G CNGB1 | 4.25e-08 | 526 | 143 | 18 | GO:0022803 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA1A GRIA1 RYR2 ITPR1 ZACN KCNC1 NALCN KCNC3 TRPM3 SCN5A PKD1 CACNA1I CACNA1G CNGB1 | 1.80e-07 | 343 | 143 | 14 | GO:0005261 |
| GeneOntologyMolecularFunction | KDEL sequence binding | 3.60e-07 | 3 | 143 | 3 | GO:0005046 | |
| GeneOntologyMolecularFunction | calcium channel activity | 3.80e-07 | 129 | 143 | 9 | GO:0005262 | |
| GeneOntologyMolecularFunction | gated channel activity | GABRD CACNA1A GRIA1 RYR2 ITPR1 ZACN CLCN1 KCNC1 KCNC3 BEST4 CACNA1I CACNA1G CNGB1 | 8.64e-07 | 334 | 143 | 13 | GO:0022836 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1A SLC38A4 GRIA1 SLC1A3 RYR2 ITPR1 ZACN KCNC1 NALCN KCNC3 TRPM3 SCN5A PKD1 CACNA1I CACNA1G SLC4A4 CNGB1 SLC23A2 | 1.30e-06 | 664 | 143 | 18 | GO:0008324 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.43e-06 | 151 | 143 | 9 | GO:0015085 | |
| GeneOntologyMolecularFunction | lipid transporter activity | ABCC4 ATG9B GLTP SLC43A3 XKR4 TTPA ABCA9 SLCO2A1 NPC1L1 ABCB11 | 1.52e-06 | 196 | 143 | 10 | GO:0005319 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1A SLC38A4 GRIA1 SLC1A3 RYR2 ITPR1 KCNC1 NALCN KCNC3 TRPM3 SCN5A PKD1 CACNA1I CACNA1G SLC4A4 CNGB1 SLC23A2 | 2.62e-06 | 627 | 143 | 17 | GO:0022890 |
| GeneOntologyMolecularFunction | ER retention sequence binding | 3.56e-06 | 5 | 143 | 3 | GO:0046923 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | SLC38A4 SLC1A3 NALCN SCN5A CACNA1I CACNA1G SLC4A4 CNGB1 SLC23A2 | 4.01e-06 | 171 | 143 | 9 | GO:0015081 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | ABCC4 SLC38A4 GRIA1 SLC43A3 SLC1A3 MFSD12 SLC19A1 ABCB11 SLC23A2 | 1.87e-05 | 207 | 143 | 9 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | ABCC4 SLC38A4 GRIA1 SLC43A3 SLC1A3 MFSD12 SLC19A1 ABCB11 SLC23A2 | 1.94e-05 | 208 | 143 | 9 | GO:0005342 |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 3.34e-05 | 26 | 143 | 4 | GO:0005248 | |
| GeneOntologyMolecularFunction | sodium channel activity | 3.48e-05 | 52 | 143 | 5 | GO:0005272 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCC4 SLC38A4 SLC1A3 ABCA9 MFSD12 SLC4A1 SLC19A1 SLCO2A1 SLC35D3 ABCB11 SLC4A4 SLC23A2 SLC35A5 | 4.00e-05 | 477 | 143 | 13 | GO:0022804 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC38A4 SLC1A3 MFSD12 SLC4A1 SLC19A1 SLCO2A1 SLC35D3 SLC4A4 SLC23A2 SLC35A5 | 5.55e-05 | 296 | 143 | 10 | GO:0015291 |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 9.90e-05 | 34 | 143 | 4 | GO:0042910 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.24e-04 | 14 | 143 | 3 | GO:0008331 | |
| GeneOntologyMolecularFunction | low voltage-gated calcium channel activity | 1.52e-04 | 3 | 143 | 2 | GO:0008332 | |
| GeneOntologyMolecularFunction | cyclic nucleotide binding | 1.71e-04 | 39 | 143 | 4 | GO:0030551 | |
| GeneOntologyMolecularFunction | ABC-type bile acid transporter activity | 3.03e-04 | 4 | 143 | 2 | GO:0015432 | |
| GeneOntologyMolecularFunction | vitamin E binding | 3.03e-04 | 4 | 143 | 2 | GO:0008431 | |
| GeneOntologyMolecularFunction | group III metabotropic glutamate receptor activity | 3.03e-04 | 4 | 143 | 2 | GO:0001642 | |
| GeneOntologyMolecularFunction | ATPase-coupled organic acid transmembrane transporter activity | 3.03e-04 | 4 | 143 | 2 | GO:0033283 | |
| GeneOntologyMolecularFunction | ATPase-coupled monocarboxylic acid transmembrane transporter activity | 3.03e-04 | 4 | 143 | 2 | GO:0033285 | |
| GeneOntologyMolecularFunction | ATPase-coupled carboxylic acid transmembrane transporter activity | 3.03e-04 | 4 | 143 | 2 | GO:0033284 | |
| GeneOntologyMolecularFunction | signal sequence binding | 4.85e-04 | 51 | 143 | 4 | GO:0005048 | |
| GeneOntologyMolecularFunction | peptide binding | 4.86e-04 | 318 | 143 | 9 | GO:0042277 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 4.89e-04 | 193 | 143 | 7 | GO:0015276 | |
| GeneOntologyMolecularFunction | peptide YY receptor activity | 5.02e-04 | 5 | 143 | 2 | GO:0001601 | |
| GeneOntologyMolecularFunction | guanine nucleotide transmembrane transporter activity | 5.02e-04 | 5 | 143 | 2 | GO:0001409 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 5.52e-04 | 197 | 143 | 7 | GO:0022834 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 7.72e-04 | 151 | 143 | 6 | GO:0008509 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 8.46e-04 | 59 | 143 | 4 | GO:0015932 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 9.27e-04 | 27 | 143 | 3 | GO:0008066 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 9.55e-04 | 105 | 143 | 5 | GO:0015171 | |
| GeneOntologyMolecularFunction | Fc-gamma receptor I complex binding | 1.04e-03 | 7 | 143 | 2 | GO:0034988 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR5B3 OR5M10 OR5M1 OR2B2 OR10P1 OR8U9 OR52I1 OR5J2 OR52E5 OR52A1 | 1.10e-03 | 431 | 143 | 10 | GO:0004984 |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.40e-03 | 31 | 143 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.47e-03 | 171 | 143 | 6 | GO:0015103 | |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 1.53e-03 | 32 | 143 | 3 | GO:0015106 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.68e-03 | 33 | 143 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor activity | 1.77e-03 | 9 | 143 | 2 | GO:0098988 | |
| GeneOntologyMolecularFunction | ATPase-coupled lipid transmembrane transporter activity | 1.77e-03 | 9 | 143 | 2 | GO:0034040 | |
| GeneOntologyMolecularFunction | adenylate cyclase inhibiting G protein-coupled glutamate receptor activity | 1.77e-03 | 9 | 143 | 2 | GO:0001640 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 1.87e-03 | 73 | 143 | 4 | GO:0170055 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 1.99e-03 | 35 | 143 | 3 | GO:0005343 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4-bisphosphate binding | 1.99e-03 | 35 | 143 | 3 | GO:0043325 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 2.01e-03 | 182 | 143 | 6 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 2.13e-03 | 184 | 143 | 6 | GO:0022832 | |
| GeneOntologyMolecularFunction | odorant binding | 2.22e-03 | 127 | 143 | 5 | GO:0005549 | |
| GeneOntologyMolecularFunction | organic acid binding | 2.39e-03 | 254 | 143 | 7 | GO:0043177 | |
| GeneOntologyMolecularFunction | pyrimidine nucleotide-sugar transmembrane transporter activity | 2.68e-03 | 11 | 143 | 2 | GO:0015165 | |
| GeneOntologyMolecularFunction | neuropeptide Y receptor activity | 2.68e-03 | 11 | 143 | 2 | GO:0004983 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 2.74e-03 | 81 | 143 | 4 | GO:0015370 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 3.14e-03 | 41 | 143 | 3 | GO:0015175 | |
| GeneOntologyMolecularFunction | antiporter activity | 3.18e-03 | 138 | 143 | 5 | GO:0015297 | |
| GeneOntologyMolecularFunction | histone ubiquitin ligase activity | 3.21e-03 | 12 | 143 | 2 | GO:0140852 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 3.38e-03 | 140 | 143 | 5 | GO:0099094 | |
| GeneOntologyMolecularFunction | G-protein alpha-subunit binding | 3.60e-03 | 43 | 143 | 3 | GO:0001965 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 4.36e-03 | 46 | 143 | 3 | GO:0005245 | |
| GeneOntologyMolecularFunction | nucleotide-sugar transmembrane transporter activity | 4.38e-03 | 14 | 143 | 2 | GO:0005338 | |
| GeneOntologyMolecularFunction | prostaglandin transmembrane transporter activity | 4.38e-03 | 14 | 143 | 2 | GO:0015132 | |
| GeneOntologyMolecularFunction | glutamate binding | 4.38e-03 | 14 | 143 | 2 | GO:0016595 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 4.50e-03 | 93 | 143 | 4 | GO:0097110 | |
| GeneOntologyMolecularFunction | symporter activity | 4.53e-03 | 150 | 143 | 5 | GO:0015293 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 4.79e-03 | 152 | 143 | 5 | GO:0022843 | |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 5.03e-03 | 15 | 143 | 2 | GO:0008559 | |
| GeneOntologyMolecularFunction | icosanoid transmembrane transporter activity | 5.03e-03 | 15 | 143 | 2 | GO:0071714 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 5.21e-03 | 49 | 143 | 3 | GO:0140359 | |
| GeneOntologyMolecularFunction | cytokine receptor activity | 5.22e-03 | 97 | 143 | 4 | GO:0004896 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein serine/threonine kinase activator activity | 5.72e-03 | 16 | 143 | 2 | GO:0061575 | |
| GeneOntologyMolecularFunction | cGMP binding | 5.72e-03 | 16 | 143 | 2 | GO:0030553 | |
| GeneOntologyMolecularFunction | adenylate cyclase binding | 5.72e-03 | 16 | 143 | 2 | GO:0008179 | |
| GeneOntologyMolecularFunction | amide binding | 5.83e-03 | 299 | 143 | 7 | GO:0033218 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 7.23e-03 | 18 | 143 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 7.57e-03 | 239 | 143 | 6 | GO:0031406 | |
| GeneOntologyBiologicalProcess | organic anion transport | CACNA1A ABCC4 NPY5R GLTP RBP5 SLC38A4 SLC43A3 SLC1A3 MFSD12 SLC4A1 SLC19A1 SLCO2A1 BEST4 SLC35D3 ABCB11 SLC4A4 SLC23A2 HRH3 | 1.35e-08 | 515 | 140 | 18 | GO:0015711 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | GABRD CACNA1A ABCC4 SLC38A4 GRIA1 SLC1A3 RYR2 SLC4A1 ITPR1 ZACN ADRB2 CLCN1 KCNC1 NALCN KCNC3 TRPM3 SLC19A1 BEST4 SCN5A PKD1 CACNA1I CACNA1G NR3C2 SLC4A4 CNGB1 SLC23A2 | 2.96e-08 | 1115 | 140 | 26 | GO:0034220 |
| GeneOntologyBiologicalProcess | regulation of membrane potential | GABRD CACNA1A GRIA1 RYR2 ADRB2 CLCN1 KCNC1 NALCN KCNC3 GCLC SCN5A CACNA1I POPDC3 CACNA1G NR3C2 SLC4A4 CNGB1 | 2.57e-07 | 559 | 140 | 17 | GO:0042391 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | GABRD CACNA1A ABCC4 SLC38A4 GRIA1 SLC1A3 RYR2 SLC4A1 ITPR1 ZACN ADRB2 CLCN1 KCNC1 NALCN KCNC3 TRPM3 SLC19A1 BEST4 SCN5A PKD1 CACNA1I CACNA1G NR3C2 SLC4A4 CNGB1 SLC23A2 HRH3 | 4.90e-07 | 1374 | 140 | 27 | GO:0006811 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR5B3 OR5M10 NPY6R NPY5R OR5M1 OR2B2 GPR34 OR10P1 ADGRV1 SUCNR1 GRM4 GRM8 OR8U9 ITPR1 ADGRG7 OR52I1 TAS2R16 OR5J2 ADRB2 ACKR3 OR52E5 NR3C2 TAS2R45 CNGB1 OR52A1 CX3CR1 HRH3 | 6.58e-07 | 1395 | 140 | 27 | GO:0007186 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | GABRD CACNA1A SLC38A4 SLC1A3 RYR2 SLC4A1 ITPR1 ADRB2 CLCN1 KCNC1 NALCN KCNC3 TRPM3 BEST4 SCN5A PKD1 CACNA1I CACNA1G NR3C2 SLC4A4 CNGB1 SLC23A2 | 1.39e-06 | 1017 | 140 | 22 | GO:0098660 |
| GeneOntologyBiologicalProcess | lipid transport | ABCC4 ATG9B GLTP RBP5 SLC43A3 XKR6 XKR4 TTPA ABCA9 SLC4A1 SLCO2A1 NPC1L1 ABCB11 PDZD8 HRH3 | 1.88e-06 | 506 | 140 | 15 | GO:0006869 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR5B3 OR5M10 PDE6C OR5M1 OR2B2 OR10P1 ADGRV1 GRM8 RYR2 OR8U9 OR52I1 TAS2R16 OR5J2 PKD1 OR52E5 TAS2R45 CNGB1 OR52A1 | 1.98e-06 | 722 | 140 | 18 | GO:0051606 |
| GeneOntologyBiologicalProcess | carboxylic acid transport | CACNA1A ABCC4 NPY5R RBP5 SLC38A4 SLC43A3 SLC1A3 MFSD12 SLC19A1 SLCO2A1 ABCB11 SLC23A2 HRH3 | 4.58e-06 | 410 | 140 | 13 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | CACNA1A ABCC4 NPY5R RBP5 SLC38A4 SLC43A3 SLC1A3 MFSD12 SLC19A1 SLCO2A1 ABCB11 SLC23A2 HRH3 | 4.83e-06 | 412 | 140 | 13 | GO:0015849 |
| GeneOntologyBiologicalProcess | lipid localization | ABCC4 ATG9B GLTP RBP5 SLC43A3 XKR6 XKR4 TTPA ABCA9 SLC4A1 SLCO2A1 NPC1L1 ABCB11 PDZD8 HRH3 | 7.14e-06 | 565 | 140 | 15 | GO:0010876 |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 9.97e-06 | 153 | 140 | 8 | GO:0098656 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR5B3 OR5M10 OR5M1 OR2B2 OR10P1 ADGRV1 GRM8 OR8U9 OR52I1 TAS2R16 OR5J2 OR52E5 TAS2R45 CNGB1 OR52A1 | 1.02e-05 | 582 | 140 | 15 | GO:0050906 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR5B3 OR5M10 OR5M1 OR2B2 OR10P1 RYR2 OR8U9 OR52I1 TAS2R16 OR5J2 OR52E5 TAS2R45 CNGB1 OR52A1 | 1.37e-05 | 524 | 140 | 14 | GO:0009593 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA1A SLC38A4 SLC1A3 RYR2 ITPR1 ZACN ADRB2 KCNC1 NALCN KCNC3 TRPM3 SCN5A PKD1 CACNA1I CACNA1G NR3C2 SLC4A4 CNGB1 SLC23A2 | 2.09e-05 | 942 | 140 | 19 | GO:0098655 |
| GeneOntologyBiologicalProcess | positive regulation of cytosolic calcium ion concentration | 2.29e-05 | 224 | 140 | 9 | GO:0007204 | |
| GeneOntologyBiologicalProcess | protein retention in ER lumen | 2.50e-05 | 9 | 140 | 3 | GO:0006621 | |
| GeneOntologyBiologicalProcess | plasma membrane phospholipid scrambling | 2.71e-05 | 26 | 140 | 4 | GO:0017121 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR5B3 OR5M10 OR5M1 OR2B2 OR10P1 OR8U9 OR52I1 TAS2R16 OR5J2 OR52E5 TAS2R45 CNGB1 OR52A1 | 2.72e-05 | 485 | 140 | 13 | GO:0050907 |
| GeneOntologyBiologicalProcess | SA node cell to atrial cardiac muscle cell signaling | 3.55e-05 | 10 | 140 | 3 | GO:0086018 | |
| GeneOntologyBiologicalProcess | SA node cell action potential | 3.55e-05 | 10 | 140 | 3 | GO:0086015 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 3.63e-05 | 183 | 140 | 8 | GO:0006820 | |
| GeneOntologyBiologicalProcess | SA node cell to atrial cardiac muscle cell communication | 4.85e-05 | 11 | 140 | 3 | GO:0086070 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNA1A SLC38A4 SLC1A3 RYR2 ITPR1 ADRB2 KCNC1 NALCN KCNC3 TRPM3 SCN5A PKD1 CACNA1I CACNA1G NR3C2 SLC4A4 CNGB1 SLC23A2 | 5.36e-05 | 922 | 140 | 18 | GO:0098662 |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell signaling | 6.44e-05 | 12 | 140 | 3 | GO:0086027 | |
| GeneOntologyBiologicalProcess | AV node cell action potential | 6.44e-05 | 12 | 140 | 3 | GO:0086016 | |
| GeneOntologyBiologicalProcess | action potential | 7.04e-05 | 201 | 140 | 8 | GO:0001508 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 8.95e-05 | 208 | 140 | 8 | GO:0035725 | |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR5B3 OR5M10 OR5M1 OR2B2 OR10P1 OR8U9 OR52I1 TAS2R16 OR5J2 OR52E5 TAS2R45 CNGB1 OR52A1 | 9.27e-05 | 547 | 140 | 13 | GO:0007606 |
| GeneOntologyBiologicalProcess | sodium ion transport | SLC38A4 ADRB2 NALCN SCN5A CACNA1I CACNA1G SLC4A4 CNGB1 SLC23A2 | 1.12e-04 | 275 | 140 | 9 | GO:0006814 |
| GeneOntologyBiologicalProcess | response to arsenic-containing substance | 1.13e-04 | 37 | 140 | 4 | GO:0046685 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 1.16e-04 | 112 | 140 | 6 | GO:0019226 | |
| GeneOntologyBiologicalProcess | organophosphate ester transport | 1.21e-04 | 162 | 140 | 7 | GO:0015748 | |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell communication | 1.31e-04 | 15 | 140 | 3 | GO:0086067 | |
| GeneOntologyBiologicalProcess | maintenance of protein localization in endoplasmic reticulum | 1.31e-04 | 15 | 140 | 3 | GO:0035437 | |
| GeneOntologyBiologicalProcess | metal ion transport | CACNA1A SLC38A4 SLC1A3 RYR2 ITPR1 ADRB2 KCNC1 NALCN KCNC3 TRPM3 SCN5A PKD1 CACNA1I CACNA1G NR3C2 SLC4A4 CNGB1 SLC23A2 | 1.50e-04 | 1000 | 140 | 18 | GO:0030001 |
| GeneOntologyBiologicalProcess | membrane depolarization | 1.78e-04 | 121 | 140 | 6 | GO:0051899 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 1.79e-04 | 230 | 140 | 8 | GO:0098739 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR5B3 OR5M10 OR5M1 OR2B2 OR10P1 OR8U9 OR52I1 OR5J2 OR52E5 CNGB1 OR52A1 | 1.81e-04 | 432 | 140 | 11 | GO:0050911 |
| GeneOntologyBiologicalProcess | positive regulation of acute inflammatory response | 1.86e-04 | 42 | 140 | 4 | GO:0002675 | |
| GeneOntologyBiologicalProcess | regulation of cytosolic calcium ion concentration | 2.69e-04 | 84 | 140 | 5 | GO:0051480 | |
| GeneOntologyBiologicalProcess | xenobiotic transmembrane transport | 2.74e-04 | 19 | 140 | 3 | GO:0006855 | |
| GeneOntologyBiologicalProcess | response to mechanical stimulus | 2.90e-04 | 247 | 140 | 8 | GO:0009612 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNA1A SLC38A4 SLC1A3 RYR2 ITPR1 ZACN ADRB2 KCNC1 NALCN KCNC3 TRPM3 SCN5A PKD1 CACNA1I CACNA1G NR3C2 SLC4A4 CNGB1 SLC23A2 | 3.12e-04 | 1157 | 140 | 19 | GO:0006812 |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 3.14e-04 | 48 | 140 | 4 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 3.14e-04 | 48 | 140 | 4 | GO:1902656 | |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR5B3 OR5M10 OR5M1 OR2B2 OR10P1 OR8U9 OR52I1 OR5J2 OR52E5 CNGB1 OR52A1 | 3.39e-04 | 465 | 140 | 11 | GO:0007608 |
| GeneOntologyBiologicalProcess | sensory perception | OR5B3 OR5M10 PDE6C OR5M1 OR2B2 OR10P1 ADGRV1 GRM8 SLC1A3 OR8U9 OR52I1 TAS2R16 OR5J2 OR52E5 TAS2R45 CNGB1 NIPBL OR52A1 | 3.49e-04 | 1072 | 140 | 18 | GO:0007600 |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | CACNA1A RYR2 ITPR1 ADRB2 NALCN TRPM3 PKD1 CACNA1I CACNA1G CNGB1 | 3.52e-04 | 392 | 140 | 10 | GO:0070588 |
| GeneOntologyBiologicalProcess | protein localization to endoplasmic reticulum | 3.71e-04 | 90 | 140 | 5 | GO:0070972 | |
| GeneOntologyBiologicalProcess | amino acid transport | 3.78e-04 | 195 | 140 | 7 | GO:0006865 | |
| GeneOntologyBiologicalProcess | macrophage activation involved in immune response | 4.29e-04 | 22 | 140 | 3 | GO:0002281 | |
| GeneOntologyBiologicalProcess | membrane depolarization during SA node cell action potential | 4.51e-04 | 5 | 140 | 2 | GO:0086046 | |
| GeneOntologyBiologicalProcess | retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum | 4.60e-04 | 53 | 140 | 4 | GO:0006890 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative transport | 5.00e-04 | 96 | 140 | 5 | GO:1901264 | |
| GeneOntologyBiologicalProcess | phospholipid translocation | 5.30e-04 | 55 | 140 | 4 | GO:0045332 | |
| GeneOntologyBiologicalProcess | vitamin transport | 5.68e-04 | 56 | 140 | 4 | GO:0051180 | |
| GeneOntologyBiologicalProcess | vitamin E metabolic process | 6.74e-04 | 6 | 140 | 2 | GO:0042360 | |
| GeneOntologyBiologicalProcess | Purkinje myocyte to ventricular cardiac muscle cell communication | 6.74e-04 | 6 | 140 | 2 | GO:0086068 | |
| GeneOntologyBiologicalProcess | membrane depolarization during AV node cell action potential | 6.74e-04 | 6 | 140 | 2 | GO:0086045 | |
| GeneOntologyBiologicalProcess | Purkinje myocyte to ventricular cardiac muscle cell signaling | 6.74e-04 | 6 | 140 | 2 | GO:0086029 | |
| GeneOntologyBiologicalProcess | lipid translocation | 7.38e-04 | 60 | 140 | 4 | GO:0034204 | |
| GeneOntologyBiologicalProcess | phospholipid transport | 7.85e-04 | 106 | 140 | 5 | GO:0015914 | |
| GeneOntologyBiologicalProcess | regulation of acute inflammatory response to antigenic stimulus | 7.94e-04 | 27 | 140 | 3 | GO:0002864 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 8.88e-04 | 63 | 140 | 4 | GO:0019228 | |
| GeneOntologyBiologicalProcess | osteoclast fusion | 9.39e-04 | 7 | 140 | 2 | GO:0072675 | |
| GeneOntologyBiologicalProcess | xenobiotic transport | 9.42e-04 | 64 | 140 | 4 | GO:0042908 | |
| GeneOntologyBiologicalProcess | import into cell | IL10RA CACNA1A BTBD8 SLC38A4 GRIA1 XKR6 XKR4 SLC1A3 ADRB2 KCNC3 SLC19A1 IGHG3 ACKR3 IGHG4 SCN5A CACNA1I CACNA1G | 9.91e-04 | 1074 | 140 | 17 | GO:0098657 |
| GeneOntologyBiologicalProcess | regulation of membrane lipid distribution | 9.99e-04 | 65 | 140 | 4 | GO:0097035 | |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 1.01e-03 | 112 | 140 | 5 | GO:1902476 | |
| GeneOntologyBiologicalProcess | protein tetramerization | 1.05e-03 | 113 | 140 | 5 | GO:0051262 | |
| GeneOntologyBiologicalProcess | regulation of acute inflammatory response | 1.12e-03 | 67 | 140 | 4 | GO:0002673 | |
| GeneOntologyBiologicalProcess | presynaptic modulation of chemical synaptic transmission | 1.12e-03 | 67 | 140 | 4 | GO:0099171 | |
| GeneOntologyBiologicalProcess | cranial nerve development | 1.12e-03 | 67 | 140 | 4 | GO:0021545 | |
| GeneOntologyBiologicalProcess | positive regulation of type I hypersensitivity | 1.25e-03 | 8 | 140 | 2 | GO:0001812 | |
| GeneOntologyBiologicalProcess | phagocytosis, engulfment | 1.25e-03 | 69 | 140 | 4 | GO:0006911 | |
| GeneOntologyBiologicalProcess | membrane organization | ATG9B GLTP BTBD8 ATR BET1L XKR6 HUWE1 DCSTAMP XKR4 TTPA SLC4A1 GCLC IGHG3 IGHG4 EXOC6B | 1.39e-03 | 914 | 140 | 15 | GO:0061024 |
| GeneOntologyBiologicalProcess | inorganic anion transport | 1.45e-03 | 180 | 140 | 6 | GO:0015698 | |
| GeneOntologyBiologicalProcess | circulatory system process | ABCC4 SUCNR1 SLC1A3 RYR2 ADRB2 GCLC SLC19A1 SCN5A CACNA1G NR3C2 SLC4A4 SLC23A2 HRH3 | 1.48e-03 | 733 | 140 | 13 | GO:0003013 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | GABRD CACNA1A GRIA1 RYR2 CLCN1 KCNC1 NALCN KCNC3 BEST4 SCN5A PKD1 CACNA1I CACNA1G CNGB1 | 3.69e-07 | 378 | 144 | 14 | GO:0034702 |
| GeneOntologyCellularComponent | transporter complex | GABRD CACNA1A PEX13 GRIA1 RYR2 ZACN CLCN1 KCNC1 NALCN KCNC3 BEST4 SCN5A PKD1 CACNA1I CACNA1G CNGB1 | 1.31e-06 | 550 | 144 | 16 | GO:1990351 |
| GeneOntologyCellularComponent | transmembrane transporter complex | GABRD CACNA1A GRIA1 RYR2 ZACN CLCN1 KCNC1 NALCN KCNC3 BEST4 SCN5A PKD1 CACNA1I CACNA1G CNGB1 | 3.40e-06 | 523 | 144 | 15 | GO:1902495 |
| GeneOntologyCellularComponent | neuronal cell body membrane | 1.13e-05 | 43 | 144 | 5 | GO:0032809 | |
| GeneOntologyCellularComponent | cell body membrane | 1.76e-05 | 47 | 144 | 5 | GO:0044298 | |
| GeneOntologyCellularComponent | cation channel complex | 3.75e-05 | 235 | 144 | 9 | GO:0034703 | |
| GeneOntologyCellularComponent | Golgi-associated vesicle membrane | 6.31e-05 | 61 | 144 | 5 | GO:0030660 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | ABCC4 SLC43A3 SLC1A3 SLC4A1 SLC19A1 SLCO2A1 PKD1 ABCB11 SLC4A4 SLC23A2 | 7.72e-05 | 320 | 144 | 10 | GO:0016323 |
| GeneOntologyCellularComponent | membrane protein complex | GABRD CACNA1A BTBD8 BET1L GRIA1 SLC1A3 RYR2 SLC4A1 ZACN GJB5 CLCN1 PIGC KCNC1 NALCN APH1A KCNC3 BEST4 SCN5A PKD1 CACNA1I CACNA1G OSMR RNF139 CNGB1 | 8.79e-05 | 1498 | 144 | 24 | GO:0098796 |
| GeneOntologyCellularComponent | Golgi-associated vesicle | 1.39e-04 | 114 | 144 | 6 | GO:0005798 | |
| GeneOntologyCellularComponent | calcium channel complex | 1.49e-04 | 73 | 144 | 5 | GO:0034704 | |
| GeneOntologyCellularComponent | basal plasma membrane | ABCC4 SLC43A3 SLC1A3 SLC4A1 SLC19A1 SLCO2A1 PKD1 ABCB11 SLC4A4 SLC23A2 | 1.76e-04 | 354 | 144 | 10 | GO:0009925 |
| GeneOntologyCellularComponent | cell projection membrane | FGD2 SLC38A4 GRIA1 ADGRV1 KCNC1 KCNC3 SLC19A1 NPC1L1 PKD1 PLEKHA1 CNGB1 | 2.02e-04 | 431 | 144 | 11 | GO:0031253 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 2.03e-04 | 17 | 144 | 3 | GO:0001518 | |
| GeneOntologyCellularComponent | cell surface | ABCC4 MUC16 GRIA1 ADGRV1 DCSTAMP SUCNR1 SLC1A3 SLC4A1 TAS2R16 KCNC1 IGHG3 ACKR3 IGHG4 SCN5A PKD1 ABCB11 OSMR SLC4A4 CX3CR1 | 2.29e-04 | 1111 | 144 | 19 | GO:0009986 |
| GeneOntologyCellularComponent | COPI-coated vesicle membrane | 2.86e-04 | 19 | 144 | 3 | GO:0030663 | |
| GeneOntologyCellularComponent | basal part of cell | ABCC4 SLC43A3 SLC1A3 SLC4A1 SLC19A1 SLCO2A1 PKD1 ABCB11 SLC4A4 SLC23A2 | 2.98e-04 | 378 | 144 | 10 | GO:0045178 |
| GeneOntologyCellularComponent | platelet dense granule | 3.89e-04 | 21 | 144 | 3 | GO:0042827 | |
| GeneOntologyCellularComponent | Golgi membrane | KDELR2 KDELR3 ATG9B SAMD8 BET1L SMPD4 HUWE1 GCNT2 XYLT1 APH1A PKD1 KDELR1 ABCB11 SLC35A5 | 4.69e-04 | 721 | 144 | 14 | GO:0000139 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | DPAGT1 KDELR2 KDELR3 ATG9B SAMD8 GRIA1 SMPD4 SSR3 DCSTAMP RYR2 ITPR1 PIGC APH1A SCD SLC35D3 KDELR1 PDZD8 PDIA5 NR3C2 RNF139 | 5.67e-04 | 1293 | 144 | 20 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | DPAGT1 KDELR2 KDELR3 ATG9B SAMD8 GRIA1 SMPD4 SSR3 DCSTAMP RYR2 ITPR1 PIGC APH1A SCD SLC35D3 KDELR1 PDZD8 PDIA5 NR3C2 RNF139 | 6.01e-04 | 1299 | 144 | 20 | GO:0098827 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | KDELR2 KDELR3 ABCC4 ATG9B BTBD8 ATR FGD2 GRIA1 DCSTAMP MFSD12 ITPR1 ADRB2 APH1A SLC35D3 NPC1L1 PKD1 KDELR1 ABCB11 CNGB1 CX3CR1 | 6.49e-04 | 1307 | 144 | 20 | GO:0030659 |
| GeneOntologyCellularComponent | platelet dense granule membrane | 6.94e-04 | 6 | 144 | 2 | GO:0031088 | |
| GeneOntologyCellularComponent | vesicle membrane | KDELR2 KDELR3 ABCC4 ATG9B BTBD8 ATR FGD2 GRIA1 DCSTAMP MFSD12 ITPR1 ADRB2 APH1A SLC35D3 NPC1L1 PKD1 KDELR1 ABCB11 CNGB1 CX3CR1 | 7.70e-04 | 1325 | 144 | 20 | GO:0012506 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | DPAGT1 KDELR2 KDELR3 ATG9B SAMD8 GRIA1 SMPD4 SSR3 DCSTAMP RYR2 ITPR1 PIGC APH1A SCD SLC35D3 KDELR1 PDZD8 PDIA5 NR3C2 RNF139 | 7.84e-04 | 1327 | 144 | 20 | GO:0042175 |
| GeneOntologyCellularComponent | GABA-ergic synapse | 9.73e-04 | 164 | 144 | 6 | GO:0098982 | |
| GeneOntologyCellularComponent | sodium channel complex | 1.03e-03 | 29 | 144 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | presynapse | CACNA1A NPY5R BTBD8 ATR GRIA1 GRM4 GRM8 ITPR1 KCNC1 APH1A KCNC3 SLC35D3 NR3C2 CNGB1 HRH3 | 1.20e-03 | 886 | 144 | 15 | GO:0098793 |
| GeneOntologyCellularComponent | COPI-coated vesicle | 1.50e-03 | 33 | 144 | 3 | GO:0030137 | |
| GeneOntologyCellularComponent | sarcolemma | 2.06e-03 | 190 | 144 | 6 | GO:0042383 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 2.08e-03 | 78 | 144 | 4 | GO:0048787 | |
| GeneOntologyCellularComponent | synaptic membrane | GABRD CACNA1A GRIA1 NBEA GRM4 GRM8 ITPR1 ADRB2 KCNC1 APH1A KCNC3 | 2.39e-03 | 583 | 144 | 11 | GO:0097060 |
| GeneOntologyCellularComponent | neuron projection membrane | 2.49e-03 | 82 | 144 | 4 | GO:0032589 | |
| GeneOntologyCellularComponent | presynaptic active zone | 2.96e-03 | 141 | 144 | 5 | GO:0048786 | |
| GeneOntologyCellularComponent | presynaptic membrane | 3.13e-03 | 277 | 144 | 7 | GO:0042734 | |
| GeneOntologyCellularComponent | leading edge membrane | 3.38e-03 | 210 | 144 | 6 | GO:0031256 | |
| GeneOntologyCellularComponent | coated vesicle membrane | 3.80e-03 | 215 | 144 | 6 | GO:0030662 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 3.91e-03 | 46 | 144 | 3 | GO:0005891 | |
| GeneOntologyCellularComponent | IgG immunoglobulin complex | 4.06e-03 | 14 | 144 | 2 | GO:0071735 | |
| Domain | Ion_trans_dom | CACNA1A RYR2 ITPR1 KCNC1 NALCN KCNC3 TRPM3 SCN5A CACNA1I CACNA1G CNGB1 | 8.06e-10 | 114 | 138 | 11 | IPR005821 |
| Domain | Ion_trans | CACNA1A RYR2 ITPR1 KCNC1 NALCN KCNC3 TRPM3 SCN5A CACNA1I CACNA1G CNGB1 | 8.06e-10 | 114 | 138 | 11 | PF00520 |
| Domain | Channel_four-helix_dom | 2.00e-07 | 57 | 138 | 7 | IPR027359 | |
| Domain | - | 2.00e-07 | 57 | 138 | 7 | 1.20.120.350 | |
| Domain | ER_ret_rcpt | 3.95e-07 | 3 | 138 | 3 | IPR000133 | |
| Domain | ER_lumen_recept | 3.95e-07 | 3 | 138 | 3 | PF00810 | |
| Domain | ER_LUMEN_RECEPTOR_1 | 3.95e-07 | 3 | 138 | 3 | PS00951 | |
| Domain | ER_LUMEN_RECEPTOR_2 | 3.95e-07 | 3 | 138 | 3 | PS00952 | |
| Domain | 7tm_1 | OR5B3 OR5M10 NPY5R OR5M1 OR2B2 GPR34 OR10P1 SUCNR1 OR8U9 OR52I1 OR5J2 ADRB2 ACKR3 OR52E5 OR52A1 CX3CR1 HRH3 | 1.06e-05 | 677 | 138 | 17 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR5B3 OR5M10 NPY5R OR5M1 OR2B2 GPR34 OR10P1 SUCNR1 OR8U9 OR52I1 OR5J2 ADRB2 ACKR3 OR52E5 OR52A1 CX3CR1 HRH3 | 1.24e-05 | 685 | 138 | 17 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR5B3 OR5M10 NPY5R OR5M1 OR2B2 GPR34 OR10P1 SUCNR1 OR8U9 OR52I1 OR5J2 ADRB2 ACKR3 OR52E5 OR52A1 CX3CR1 HRH3 | 1.38e-05 | 691 | 138 | 17 | PS50262 |
| Domain | GPCR_Rhodpsn | OR5B3 OR5M10 NPY5R OR5M1 OR2B2 GPR34 OR10P1 SUCNR1 OR8U9 OR52I1 OR5J2 ADRB2 ACKR3 OR52E5 OR52A1 CX3CR1 HRH3 | 1.41e-05 | 692 | 138 | 17 | IPR000276 |
| Domain | GPCR_Rhodpsn_7TM | OR5B3 OR5M10 NPY5R OR5M1 OR2B2 GPR34 OR10P1 SUCNR1 OR8U9 OR52I1 OR5J2 ADRB2 ACKR3 OR52A1 CX3CR1 HRH3 | 3.61e-05 | 670 | 138 | 16 | IPR017452 |
| Domain | ARM-type_fold | PDS5B ATR NOC3L ARMH1 NBEA HEATR1 HUWE1 ITPR1 UNC79 NIPBL IPO11 | 4.43e-05 | 339 | 138 | 11 | IPR016024 |
| Domain | VDCCAlpha1 | 4.56e-05 | 10 | 138 | 3 | IPR002077 | |
| Domain | SNO | 5.42e-05 | 2 | 138 | 2 | IPR026741 | |
| Domain | SBNO_Helicase_C_dom | 5.42e-05 | 2 | 138 | 2 | IPR026937 | |
| Domain | Helicase_C_4 | 5.42e-05 | 2 | 138 | 2 | PF13871 | |
| Domain | Cyclin_Y | 5.42e-05 | 2 | 138 | 2 | IPR012399 | |
| Domain | VDCC_T_a1 | 1.62e-04 | 3 | 138 | 2 | IPR005445 | |
| Domain | HEAT_REPEAT | 1.69e-04 | 70 | 138 | 5 | PS50077 | |
| Domain | ARM-like | 1.82e-04 | 270 | 138 | 9 | IPR011989 | |
| Domain | K_chnl_volt-dep_Kv3 | 3.22e-04 | 4 | 138 | 2 | IPR003974 | |
| Domain | Olfact_rcpt | OR5B3 OR5M10 OR5M1 OR2B2 OR10P1 OR8U9 OR52I1 OR5J2 OR52E5 OR52A1 | 6.89e-04 | 393 | 138 | 10 | IPR000725 |
| Domain | RIH_assoc | 7.97e-04 | 6 | 138 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 7.97e-04 | 6 | 138 | 2 | IPR013662 | |
| Domain | RIH_dom | 7.97e-04 | 6 | 138 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 7.97e-04 | 6 | 138 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 7.97e-04 | 6 | 138 | 2 | IPR015925 | |
| Domain | - | 7.97e-04 | 6 | 138 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 7.97e-04 | 6 | 138 | 2 | PF01365 | |
| Domain | Ins145_P3_rec | 7.97e-04 | 6 | 138 | 2 | PF08709 | |
| Domain | HEAT | 8.89e-04 | 58 | 138 | 4 | IPR000357 | |
| Domain | Glyco_trans_14 | 1.47e-03 | 8 | 138 | 2 | IPR003406 | |
| Domain | Branch | 1.47e-03 | 8 | 138 | 2 | PF02485 | |
| Domain | GPCR_3_mtglu_rcpt | 1.47e-03 | 8 | 138 | 2 | IPR000162 | |
| Domain | Band3_cytoplasmic_dom | 1.89e-03 | 9 | 138 | 2 | IPR013769 | |
| Domain | Band_3_cyto | 1.89e-03 | 9 | 138 | 2 | PF07565 | |
| Domain | - | 1.89e-03 | 9 | 138 | 2 | 3.40.1100.10 | |
| Domain | Ptc/Disp | 1.89e-03 | 9 | 138 | 2 | IPR003392 | |
| Domain | Patched | 1.89e-03 | 9 | 138 | 2 | PF02460 | |
| Domain | GPS | 2.00e-03 | 34 | 138 | 3 | SM00303 | |
| Domain | GPS | 2.17e-03 | 35 | 138 | 3 | PF01825 | |
| Domain | MIR | 2.35e-03 | 10 | 138 | 2 | PS50919 | |
| Domain | MIR | 2.35e-03 | 10 | 138 | 2 | PF02815 | |
| Domain | MIR | 2.35e-03 | 10 | 138 | 2 | SM00472 | |
| Domain | HCO3_cotransp | 2.35e-03 | 10 | 138 | 2 | PF00955 | |
| Domain | HCO3_transpt_C | 2.35e-03 | 10 | 138 | 2 | IPR011531 | |
| Domain | MIR_motif | 2.35e-03 | 10 | 138 | 2 | IPR016093 | |
| Domain | PTrfase/Anion_transptr | 2.35e-03 | 10 | 138 | 2 | IPR016152 | |
| Domain | HCO3_transpt_euk | 2.35e-03 | 10 | 138 | 2 | IPR003020 | |
| Domain | GPS | 2.36e-03 | 36 | 138 | 3 | PS50221 | |
| Domain | GPS | 2.55e-03 | 37 | 138 | 3 | IPR000203 | |
| Domain | ANF_lig-bd_rcpt | 2.55e-03 | 37 | 138 | 3 | IPR001828 | |
| Domain | ANF_receptor | 2.55e-03 | 37 | 138 | 3 | PF01094 | |
| Domain | XK_rel | 2.85e-03 | 11 | 138 | 2 | IPR018629 | |
| Domain | XK-related | 2.85e-03 | 11 | 138 | 2 | PF09815 | |
| Domain | Peripla_BP_I | 2.97e-03 | 39 | 138 | 3 | IPR028082 | |
| Domain | NCD3G | 4.01e-03 | 13 | 138 | 2 | PF07562 | |
| Domain | GPCR_3_9-Cys_dom | 4.01e-03 | 13 | 138 | 2 | IPR011500 | |
| Domain | SSD | 4.01e-03 | 13 | 138 | 2 | IPR000731 | |
| Domain | SSD | 4.01e-03 | 13 | 138 | 2 | PS50156 | |
| Domain | GPCR_3_CS | 4.65e-03 | 14 | 138 | 2 | IPR017979 | |
| Domain | ABC_tran | 5.35e-03 | 48 | 138 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 5.35e-03 | 48 | 138 | 3 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 5.67e-03 | 49 | 138 | 3 | PS00211 | |
| Domain | ABC_transporter-like | 6.00e-03 | 50 | 138 | 3 | IPR003439 | |
| Domain | - | 6.18e-03 | 222 | 138 | 6 | 1.25.10.10 | |
| Pubmed | Cell-type-specific differences in KDEL receptor clustering in mammalian cells. | 7.10e-08 | 3 | 145 | 3 | 32645101 | |
| Pubmed | A molecular specificity code for the three mammalian KDEL receptors. | 7.10e-08 | 3 | 145 | 3 | 18086916 | |
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 9118249 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 5.28e-07 | 38 | 145 | 5 | 30786075 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 2.04e-06 | 139 | 145 | 7 | 16985003 | |
| Pubmed | 3.91e-06 | 8 | 145 | 3 | 34478646 | ||
| Pubmed | 5.85e-06 | 9 | 145 | 3 | 16382099 | ||
| Pubmed | Trait-associated noncoding variant regions affect TBX3 regulation and cardiac conduction. | 8.34e-06 | 10 | 145 | 3 | 32672536 | |
| Pubmed | Cardiac disease and arrhythmogenesis: Mechanistic insights from mouse models. | 1.14e-05 | 11 | 145 | 3 | 27766308 | |
| Pubmed | 1.52e-05 | 12 | 145 | 3 | 11700294 | ||
| Pubmed | Presynaptic Kv3 channels are required for fast and slow endocytosis of synaptic vesicles. | 1.73e-05 | 2 | 145 | 2 | 33508244 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 25735837 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 25142016 | ||
| Pubmed | Vitamin E decreases bone mass by stimulating osteoclast fusion. | 1.73e-05 | 2 | 145 | 2 | 22388090 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 23723061 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 12930807 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 16553620 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 25783894 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 35510987 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 21836066 | ||
| Pubmed | Behavioral motor dysfunction in Kv3-type potassium channel-deficient mice. | 1.73e-05 | 2 | 145 | 2 | 16923152 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 26627919 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 24473438 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 22777911 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 22972916 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 27188183 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 24121512 | ||
| Pubmed | Inactivation of a novel neuropeptide Y/peptide YY receptor gene in primate species. | 1.73e-05 | 2 | 145 | 2 | 8910290 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 28442571 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 18682278 | ||
| Pubmed | Ablation of Ctrp9, Ligand of AdipoR1, and Lower Number of Cone Photoreceptors in Mouse Retina. | 1.73e-05 | 2 | 145 | 2 | 35575905 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 30426302 | ||
| Pubmed | CTRP9 ameliorates cellular senescence via PGC‑1α/AMPK signaling in mesenchymal stem cells. | 1.73e-05 | 2 | 145 | 2 | 29749459 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 21204784 | ||
| Pubmed | Mutation screening of ACKR3 and COPS8 in kidney cancer cases from the CONFIRM study. | 1.73e-05 | 2 | 145 | 2 | 28063109 | |
| Pubmed | CTRP9 induces iNOS expression through JAK2/STAT3 pathway in Raw 264.7 and peritoneal macrophages. | 1.73e-05 | 2 | 145 | 2 | 31837806 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 28978553 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 32283037 | ||
| Pubmed | C1q-TNF-Related Protein-9 Promotes Cardiac Hypertrophy and Failure. | 1.73e-05 | 2 | 145 | 2 | 27821723 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 17482902 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 35008006 | ||
| Pubmed | Activation of β2-Adrenergic Receptors in Microglia Alleviates Neuropathic Hypersensitivity in Mice. | 1.73e-05 | 2 | 145 | 2 | 36672219 | |
| Pubmed | Purkinje Cells as Sources of Arrhythmias in Long QT Syndrome Type 3. | 1.73e-05 | 2 | 145 | 2 | 26289036 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 37234154 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 24030394 | ||
| Pubmed | A Golgi-based KDELR-dependent signalling pathway controls extracellular matrix degradation. | 1.73e-05 | 2 | 145 | 2 | 25682866 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 29315537 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 36766785 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 37945738 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 22514273 | ||
| Pubmed | Study of Strawberry Notch homolog 1 and 2 expression in human glioblastoma. | 1.73e-05 | 2 | 145 | 2 | 36695974 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 18495891 | ||
| Pubmed | Increased motor drive and sleep loss in mice lacking Kv3-type potassium channels. | 1.73e-05 | 2 | 145 | 2 | 15005717 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 38741428 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 29891059 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 30764693 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 29145717 | ||
| Pubmed | Genetic analysis in post-mortem samples with micro-ischemic alterations. | 1.73e-05 | 2 | 145 | 2 | 28086167 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 23734863 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 30760704 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 20016089 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 18448641 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 26419929 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 32831639 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 20547676 | ||
| Pubmed | Regulation of prostaglandin transporters in colorectal neoplasia. | 1.73e-05 | 2 | 145 | 2 | 19138942 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 37906648 | ||
| Pubmed | CTRP9 Promotes Brown Adipose Tissue Lipolysis in Mice Fed a High-Fat Diet. | 1.73e-05 | 2 | 145 | 2 | 38940054 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 15217387 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 26754066 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 11517255 | ||
| Pubmed | Astrocytic β2 Adrenergic Receptor Gene Deletion Affects Memory in Aged Mice. | 1.73e-05 | 2 | 145 | 2 | 27776147 | |
| Pubmed | CTRP9 alleviates foam cells apoptosis by enhancing cholesterol efflux. | 1.73e-05 | 2 | 145 | 2 | 33352225 | |
| Pubmed | 3.16e-05 | 143 | 145 | 6 | 20424473 | ||
| Pubmed | 3.78e-05 | 45 | 145 | 4 | 25979088 | ||
| Pubmed | 4.00e-05 | 300 | 145 | 8 | 19086053 | ||
| Pubmed | 4.13e-05 | 46 | 145 | 4 | 34815492 | ||
| Pubmed | 4.32e-05 | 92 | 145 | 5 | 20301317 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 26708753 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 11802782 | ||
| Pubmed | De novo point mutations in patients diagnosed with ataxic cerebral palsy. | 5.16e-05 | 3 | 145 | 2 | 25981959 | |
| Pubmed | Ethanol inhibition of a T-type Ca²+ channel through activity of protein kinase C. | 5.16e-05 | 3 | 145 | 2 | 23488970 | |
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 25870106 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 30167850 | ||
| Pubmed | Identification of the t-type calcium channel (Ca(v)3.1d) in developing mouse heart. | 5.16e-05 | 3 | 145 | 2 | 11230107 | |
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 25433169 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 33547341 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 22184064 | ||
| Pubmed | Calmodulin regulates Cav3 T-type channels at their gating brake. | 5.16e-05 | 3 | 145 | 2 | 28972185 | |
| Pubmed | Analysis of a cell niche with proliferative potential at the roof of the aqueduct of Sylvius. | 5.16e-05 | 3 | 145 | 2 | 36375656 | |
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 30978318 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 33068816 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 19854836 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 25050486 | ||
| Pubmed | CCNYL1, but Not CCNY, Cooperates with CDK16 to Regulate Spermatogenesis in Mouse. | 5.16e-05 | 3 | 145 | 2 | 26305884 | |
| Pubmed | CTRP9 enhances carotid plaque stability by reducing pro-inflammatory cytokines in macrophages. | 5.16e-05 | 3 | 145 | 2 | 25701788 | |
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 27353765 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 11897840 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 9473604 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 12101241 | ||
| Interaction | OPALIN interactions | KDELR2 PDS5B KDELR3 ATR SMPD4 HEATR1 INTS2 KDELR1 UCK2 IPO11 | 1.21e-06 | 209 | 132 | 10 | int:OPALIN |
| Interaction | CACNA1D interactions | 1.69e-05 | 24 | 132 | 4 | int:CACNA1D | |
| Interaction | FAM234A interactions | 1.95e-05 | 126 | 132 | 7 | int:FAM234A | |
| Interaction | KCNC3 interactions | 3.68e-05 | 29 | 132 | 4 | int:KCNC3 | |
| Interaction | SCN2B interactions | 3.80e-05 | 95 | 132 | 6 | int:SCN2B | |
| GeneFamily | Solute carriers | SLC38A4 SLC43A3 SLC1A3 SLC4A1 SLC7A4 SLC19A1 SLCO2A1 SLC35D3 SLC4A4 SLC23A2 SLC35A5 | 2.04e-05 | 395 | 106 | 11 | 752 |
| GeneFamily | Calcium voltage-gated channel subunits | 4.62e-04 | 26 | 106 | 3 | 253 | |
| GeneFamily | Glucosaminyl (N-acetyl) transferases/xylosyltransferases | 9.32e-04 | 8 | 106 | 2 | 441 | |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 9.32e-04 | 8 | 106 | 2 | 281 | |
| GeneFamily | Neuropeptide receptors | 1.49e-03 | 10 | 106 | 2 | 854 | |
| GeneFamily | Blood group antigens|XK related family | 1.81e-03 | 11 | 106 | 2 | 955 | |
| GeneFamily | Olfactory receptors, family 52 | 2.97e-03 | 49 | 106 | 3 | 165 | |
| GeneFamily | Olfactory receptors, family 5 | 4.27e-03 | 112 | 106 | 4 | 152 | |
| GeneFamily | Endogenous ligands|C1q and TNF related | 4.90e-03 | 18 | 106 | 2 | 1372 | |
| GeneFamily | Neuroblastoma breakpoint family | 7.95e-03 | 23 | 106 | 2 | 662 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | CACNA1A RALGDS GRIA1 NBEA XKR6 GRM4 XKR4 GRM8 RYR2 SLC4A1 KCNC1 NALCN PLEKHA1 CACNA1G CNGB1 UNC79 | 1.43e-06 | 703 | 142 | 16 | M39070 |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | CUL4A SLC38A4 CCNY SBNO2 ADRB2 SLC19A1 ACKR3 SCD SLCO2A1 PKD1 PDIA5 SLC23A2 | 7.70e-06 | 457 | 142 | 12 | M1613 |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | CUL4A SLC38A4 CCNY SBNO2 ADRB2 SLC19A1 ACKR3 SCD SLCO2A1 PKD1 PDIA5 SLC23A2 | 1.02e-05 | 470 | 142 | 12 | MM1053 |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-07 | 189 | 143 | 8 | 3d838da870623a6a278ddc8e6cedca85d9877e50 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-MALT_B_cells|normal_Lymph_Node / Location, Cell class and cell subclass | 1.91e-07 | 190 | 143 | 8 | 1f907016980ccfbf089e354d91d931771e8a83e0 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-Plasma_cells|B_lymphocytes / Location, Cell class and cell subclass | 2.07e-07 | 192 | 143 | 8 | 119832d4aee29ddda2485fc3e5dcdaacf833cc30 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.61e-07 | 198 | 143 | 8 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.61e-07 | 198 | 143 | 8 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | normal_Lung-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 2.40e-06 | 186 | 143 | 7 | f4d72463c5f287da6436287eda0a349b4185841e | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-06 | 186 | 143 | 7 | a1ab273b01971d6a892912560d387685dd657179 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-06 | 187 | 143 | 7 | ef3c85c01bc3da408ae288b6e3096ad888a12e63 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.86e-06 | 191 | 143 | 7 | 208cd307826b5af89f8f10c0c915f90f80a25c6c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.06e-06 | 193 | 143 | 7 | 43ffa8ecc72bebcd204279db2bde98ae48d97f90 | |
| ToppCell | metastatic_Brain-B_lymphocytes-Plasma_cells|B_lymphocytes / Location, Cell class and cell subclass | 3.17e-06 | 194 | 143 | 7 | 69828d24b3e182f26aa15eb0ae5aa21c640c2922 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 3.17e-06 | 194 | 143 | 7 | 1ca034f25a8fce503fb67654d7fa2a8ec71976be | |
| ToppCell | MS-plasma-|MS / Condition, Cell_class and T cell subcluster | 3.28e-06 | 195 | 143 | 7 | b0a51dea06899e6a4477c3436c85e114cd8f6214 | |
| ToppCell | MS-plasma|MS / Condition, Cell_class and T cell subcluster | 3.28e-06 | 195 | 143 | 7 | de866c0eaec36d94a3101eb9f949ca9544207f33 | |
| ToppCell | tumor_Lung-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 3.39e-06 | 196 | 143 | 7 | 1f63dba9d226e4a42d9bee7258580a1e547c0e92 | |
| ToppCell | B_cells-Plasma_cells_and_plasmablasts|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 3.51e-06 | 197 | 143 | 7 | 3b1c574b3d119b63967bb1306f0353ecc4c522f3 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.63e-06 | 198 | 143 | 7 | 5fc25b008a4d8d6bec83923a16f64dd9e1ff1f2d | |
| ToppCell | Transverse-B_cell-B_cell_IgG_Plasma|Transverse / Region, Cell class and subclass | 3.63e-06 | 198 | 143 | 7 | a4ece1fe3d15acfde0e6ff14cddb3a3d16f61ce0 | |
| ToppCell | Transverse-(2)_B_cell-(21)_B_cell_IgG_Plasma|Transverse / shred on region, Cell_type, and subtype | 3.63e-06 | 198 | 143 | 7 | d6052b5a44246798e90f4779cd940ffac7539fcd | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 3.87e-06 | 200 | 143 | 7 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast-MyoFB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 7.50e-06 | 145 | 143 | 6 | ac41c6c02b7d78162b86222983688f54d04ac47d | |
| ToppCell | droplet-Liver-hepatocytes-3m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.12e-06 | 147 | 143 | 6 | 00619115b9a1ec2b967c2992043b41974ece63c4 | |
| ToppCell | facs-Liver-Hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-05 | 156 | 143 | 6 | e2cda3ad4e5f44a80133864c5a38b766afb952ce | |
| ToppCell | frontal_cortex-Non-neuronal-macrophage-Macrophage-Microglia_Siglech|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.32e-05 | 160 | 143 | 6 | c3f2f362e5d0602bb997e8367b4c9a8fe88e4ea8 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue-Colon_normal_tissue-6|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.41e-05 | 162 | 143 | 6 | 7f9385aa749bfb2fa9fee6939fe46d946bc21d31 | |
| ToppCell | frontal_cortex-Non-neuronal-macrophage|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.46e-05 | 163 | 143 | 6 | b89f586b444f90047c8ce407f53847fd1ee7cca3 | |
| ToppCell | frontal_cortex-Non-neuronal-macrophage-Macrophage|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.46e-05 | 163 | 143 | 6 | cbe9b4c4b2e42e9f92a57ed66758af93434db5bb | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.57e-05 | 165 | 143 | 6 | 4b4e75ad0eb0a6b00c30a000ec6267e23ba2e496 | |
| ToppCell | facs-Heart-LV-24m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 165 | 143 | 6 | 41707e66542ea27133043740ef9e58ab89b06607 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.79e-05 | 169 | 143 | 6 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.98e-05 | 172 | 143 | 6 | 94842346c84542a5243bd765e49f4af8bc5182db | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue-Colon_normal_tissue|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.98e-05 | 172 | 143 | 6 | 5d654dd030ed22a701e15c5f09002951d99a52e8 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 2.18e-05 | 175 | 143 | 6 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 2.18e-05 | 175 | 143 | 6 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.26e-05 | 176 | 143 | 6 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-Plasma_cells|normal_Lymph_Node / Location, Cell class and cell subclass | 2.64e-05 | 181 | 143 | 6 | 949ac3b60e7fb5968da4c4e872965fb4e10f4a35 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B_plasma-Plasma_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 2.81e-05 | 183 | 143 | 6 | a6866951866373a1029e04818f4a4a31278c409d | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-05 | 183 | 143 | 6 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B_plasma|lymph-node_spleen / Manually curated celltypes from each tissue | 2.81e-05 | 183 | 143 | 6 | beadc69f511cf183e493cb445135f0748ab8b20e | |
| ToppCell | B_cell_maturation-plasma|World / Lineage and Cell class | 2.81e-05 | 183 | 143 | 6 | 0c3cb61912df05f1beba1004540770ef1a4de786 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-05 | 184 | 143 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-05 | 184 | 143 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-05 | 184 | 143 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Endothelial_Myeloid|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.98e-05 | 185 | 143 | 6 | 6b832b3e080dfadd21253ac45022192f4d3cb37b | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.17e-05 | 187 | 143 | 6 | 5ce7cf02990465b6f793205e4be07e8337b3570a | |
| ToppCell | B_cells-Plasma_cells_and_plasmablasts|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.17e-05 | 187 | 143 | 6 | 9325cadd5f2c667d526696899e7aa36a98226d4b | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-B_lymphocytic-plasma_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.17e-05 | 187 | 143 | 6 | c80e03d5aa498b4eecbc46565fabf9b5be10c71c | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.17e-05 | 187 | 143 | 6 | 17a37fc3a1d62fef3137e5ff26a84c0b8c80e124 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid-Micro|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.17e-05 | 187 | 143 | 6 | 1b0eb29394040555516677b9de75c15e769c4c53 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-05 | 187 | 143 | 6 | 1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.17e-05 | 187 | 143 | 6 | 11c773cf3dc1e725b7e4d8edd676c8a94a231d2a | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_B_plasma-Plasma_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 3.27e-05 | 188 | 143 | 6 | c7b1807c96f87fbcd37739a159cf00f9a1ff5d71 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.27e-05 | 188 | 143 | 6 | 5df5a0890e17d19f55770525345a656253696887 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.27e-05 | 188 | 143 | 6 | 9e923b0d79495ee1a3a097741a877f25d439eda3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Endothelial_Myeloid-Micro|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.27e-05 | 188 | 143 | 6 | 14dbc985abc2012c9f53deb243d465e4175f419f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.27e-05 | 188 | 143 | 6 | 0d7296ad26e97ad91c6927a6cfe4e6e70a74c5a6 | |
| ToppCell | mild-Lymphocytic-Plasmablast|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.36e-05 | 189 | 143 | 6 | db2097e6e165004d47ed504e115083a4e4f4b147 | |
| ToppCell | control-Lymphocytic-Plasmablast|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.36e-05 | 189 | 143 | 6 | 2e4c2618d06120f83cb4887dd3497b81984a8607 | |
| ToppCell | facs-Marrow-KLS-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-05 | 189 | 143 | 6 | b28a0e2d5a5f512f9b137b162b195bdc3d5ee9ba | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-plasma_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.46e-05 | 190 | 143 | 6 | 76b747bafff09bf8375a5717c9f213cbfb405bac | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 3.46e-05 | 190 | 143 | 6 | 5ec49cc7692053c1a525ca9137c996ccd2794e1c | |
| ToppCell | tumor_Lymph_Node_/_Brain-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 3.46e-05 | 190 | 143 | 6 | ce70336679a2b713836e7497e6dc48aac612b018 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.46e-05 | 190 | 143 | 6 | 84eb7761f537d270673909a71d4f122e826769d5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.46e-05 | 190 | 143 | 6 | f85cdd79eefd699ada7a91bf4997cc730a9b9846 | |
| ToppCell | severe-Lymphocytic-Plasmablast|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.57e-05 | 191 | 143 | 6 | 73660d762c9d451980c21adc426db6670bcaf37f | |
| ToppCell | facs-Brain_Myeloid|facs / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-05 | 191 | 143 | 6 | bf1135b382a3bf8cddc19538bc38361ef1fc2de1 | |
| ToppCell | COVID-19_Moderate-Plasmablast|COVID-19_Moderate / disease group, cell group and cell class | 3.67e-05 | 192 | 143 | 6 | 25c6c7a244190f82c7feab874bdec12490b7de4d | |
| ToppCell | COVID-19_Severe-Lymphoid_P|COVID-19_Severe / Disease group, lineage and cell class | 3.67e-05 | 192 | 143 | 6 | 3d0240491296757b3125f6e861bbaca06bbc5068 | |
| ToppCell | COVID-19_Severe-Lymphoid_P-Plasmablast|COVID-19_Severe / Disease group, lineage and cell class | 3.67e-05 | 192 | 143 | 6 | 90af8dad4e6f80b5ecd62027deeb2e4cea6b24bb | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.78e-05 | 193 | 143 | 6 | 227d82059a9f99937e0188ff57f2d0e485ebfe69 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.78e-05 | 193 | 143 | 6 | 38bb14df7f05c29565a1c7f175fafe636e543bf8 | |
| ToppCell | (5)_Plasma_IgG|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.78e-05 | 193 | 143 | 6 | a94ebb3bca62970d5d17b0234893918ee6b7b808 | |
| ToppCell | metastatic_Brain-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 3.78e-05 | 193 | 143 | 6 | d05535eaabb6b4069b72b23d852888d4191407fd | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.78e-05 | 193 | 143 | 6 | 3ba6d44248690b80f4caf791d463e60f1ab816c4 | |
| ToppCell | B_cell_maturation-plasma|B_cell_maturation / Lineage and Cell class | 3.78e-05 | 193 | 143 | 6 | 5415f7e54bc40aec3dbe27fd97f6e9be6db08a48 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.78e-05 | 193 | 143 | 6 | ce3873ece35fd2155ea235cb3c8bcd235cc0ebde | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.78e-05 | 193 | 143 | 6 | 8f57b0473a2c2c07f83e5fe70f16862b1bb3b514 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 193 | 143 | 6 | 5fb7808dd971c1cc64c2bd4f8f1de646fb2d77f4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-Plasma_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.89e-05 | 194 | 143 | 6 | 297286c57d7ee6338d9cf77b27eb2809378ce15d | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 4.01e-05 | 195 | 143 | 6 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | severe-Lymphocytic-Plasmablast|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.01e-05 | 195 | 143 | 6 | 43ff1eed563c647bc5b7b06ffe136210653c3a83 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.01e-05 | 195 | 143 | 6 | 1f07502597e9476345b07f9f25aeeb6c1de13013 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.12e-05 | 196 | 143 | 6 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.24e-05 | 197 | 143 | 6 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | (5)_Plasma|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 4.24e-05 | 197 | 143 | 6 | ebb15b018ee8a68e917b43e59a5fc4330d62de21 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.36e-05 | 198 | 143 | 6 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 4.36e-05 | 198 | 143 | 6 | e84c5f712e1dea548d0e2aba6625598f9671d3a0 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.36e-05 | 198 | 143 | 6 | 6ba5e5970109a04ed968bac7ff099ae250c579dc | |
| ToppCell | Sigmoid|World / shred on region, Cell_type, and subtype | 4.48e-05 | 199 | 143 | 6 | 83737cf4e511e660ec2d268447228cefc8a7ba9c | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-B-Plasmablast|COVID-19_Severe / Disease, condition lineage and cell class | 4.48e-05 | 199 | 143 | 6 | e6422b65e22e5aa8dfaebdae5be76dd78b978604 | |
| ToppCell | Sigmoid-(2)_B_cell|Sigmoid / shred on region, Cell_type, and subtype | 4.48e-05 | 199 | 143 | 6 | 646960845ede4c5b00cdfe73051d5d4577648bf8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.48e-05 | 199 | 143 | 6 | b0a906586e58009f5ed9272fc29ba28e49c85ee6 | |
| ToppCell | Sigmoid-B_cell|Sigmoid / Region, Cell class and subclass | 4.48e-05 | 199 | 143 | 6 | 997ee1b622b1e349d5e98026afbc4f8d283b2136 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 4.48e-05 | 199 | 143 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other-Macro_CHIT1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.48e-05 | 199 | 143 | 6 | 54a54ad983503ed515d476882d86b17d97892037 | |
| ToppCell | Sigmoid|World / Region, Cell class and subclass | 4.48e-05 | 199 | 143 | 6 | 5b05ba8d24b33e88800777cf2cb0d5a6c8eea1d7 | |
| ToppCell | (2)_B_cell|World / shred on Cell_type and subtype | 4.48e-05 | 199 | 143 | 6 | 751cfdbc873390bd03837a57367a290f34d53f38 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 4.61e-05 | 200 | 143 | 6 | 61d7dd0a78942b069c3f5e75044368dc00e6e8e6 | |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell-IgG_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass | 4.61e-05 | 200 | 143 | 6 | fee909730133ec9875e14f7deed2a351dd21dba4 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Mesenchymal-Unfolded_protein_responsible_cell|3m / Sample Type, Dataset, Time_group, and Cell type. | 4.61e-05 | 200 | 143 | 6 | e68e44ab57d17ac4845d9e3798814d048d79e888 | |
| Drug | riluzole | GABRD CACNA1A GRIA1 GRM4 GRM8 SLC1A3 RYR2 ITPR1 KCNC1 SCN5A PKD1 CACNA1I CACNA1G | 5.97e-11 | 174 | 140 | 13 | CID000005070 |
| Drug | potassium | CACNA1A PDS5B SLC38A4 GRM4 GRM8 SLC1A3 RYR2 SLC4A1 ITPR1 SLC7A4 ZACN ADRB2 CLCN1 KCNC1 KCNC3 BEST4 SCN5A PKD1 CACNA1I CACNA1G NR3C2 SLC4A4 CNGB1 CX3CR1 HRH3 | 2.43e-09 | 1008 | 140 | 25 | CID000000813 |
| Drug | gamma-aminobutyric acid | GABRD CACNA1A SLC38A4 GRIA1 GRM4 GRM8 SLC1A3 RYR2 ITPR1 ZACN CLCN1 BEST4 PKD1 CACNA1I CACNA1G CX3CR1 | 3.88e-08 | 474 | 140 | 16 | CID000000119 |
| Drug | lamotrigine | 4.24e-08 | 116 | 140 | 9 | CID000003878 | |
| Drug | CNS 1145 | 4.69e-08 | 33 | 140 | 6 | CID000190902 | |
| Drug | IHC-64 | 4.69e-08 | 33 | 140 | 6 | CID000162753 | |
| Drug | gabapentin | GABRD CACNA1A GRIA1 GRM8 RYR2 ITPR1 SCN5A PKD1 CACNA1I CACNA1G | 9.72e-08 | 169 | 140 | 10 | CID000003446 |
| Drug | nimodipine | 2.90e-07 | 145 | 140 | 9 | CID000004497 | |
| Drug | CAS 298-57-7 | 3.32e-07 | 73 | 140 | 7 | CID000002761 | |
| Drug | gadolinium | CACNA1A GRIA1 ADGRV1 RYR2 ITPR1 TRPM3 PKD1 CACNA1I CACNA1G NR3C2 | 4.44e-07 | 199 | 140 | 10 | CID000023982 |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 5.73e-07 | 79 | 140 | 7 | CID005287890 | |
| Drug | Cinildipine | 1.22e-06 | 56 | 140 | 6 | CID000002752 | |
| Drug | glutamate | GABRD CACNA1A SLC38A4 GRIA1 GRM4 GRM8 SLC1A3 RYR2 SLC4A1 ITPR1 ZACN CLCN1 TRPM3 COPS8 GCLC BEST4 PKD1 CACNA1I CACNA1G SLC4A4 | 1.83e-06 | 962 | 140 | 20 | CID000000611 |
| Drug | nilvadipine | 1.85e-06 | 60 | 140 | 6 | CID000004494 | |
| Drug | IAA-94 | 2.04e-06 | 61 | 140 | 6 | CID000003667 | |
| Drug | verapamil | CACNA1A ABCC4 GCNT2 ABCA9 RYR2 ITPR1 ADRB2 KCNC1 KCNC3 SCN5A PKD1 ABCB11 CACNA1I CACNA1G | 2.08e-06 | 490 | 140 | 14 | CID000002520 |
| Drug | Verapamil | 2.35e-06 | 16 | 140 | 4 | DB00661 | |
| Drug | lercanidipine | 2.47e-06 | 63 | 140 | 6 | CID000065866 | |
| Drug | nitrendipine | 2.48e-06 | 98 | 140 | 7 | CID000004507 | |
| Drug | baclofen | 2.90e-06 | 191 | 140 | 9 | CID000002284 | |
| Drug | Dantrolene-13C3 | 3.28e-06 | 145 | 140 | 8 | CID000002951 | |
| Drug | cyclothiazide | 3.46e-06 | 103 | 140 | 7 | CID000002910 | |
| Drug | 4CPG | 3.49e-06 | 38 | 140 | 5 | CID000005115 | |
| Drug | gallopamil | 3.56e-06 | 67 | 140 | 6 | CID000001234 | |
| Drug | AC1L2AC7 | 4.23e-06 | 69 | 140 | 6 | CID000068733 | |
| Drug | 3,4-dihydroquinazoline | 4.49e-06 | 6 | 140 | 3 | CID000583065 | |
| Drug | sodium | GABRD SLC38A4 GRIA1 SLC43A3 HUWE1 SLC1A3 RYR2 SLC4A1 SLC7A4 ZACN KCNC1 TRPM3 GCLC SCN5A PKD1 ABCB11 NR3C2 SLC4A4 SLC23A2 | 5.43e-06 | 944 | 140 | 19 | CID000000923 |
| Drug | ethosuximide | 6.38e-06 | 74 | 140 | 6 | CID000003291 | |
| Drug | trans-1,2-diphenylethylene | 8.07e-06 | 117 | 140 | 7 | CID000011502 | |
| Drug | nisoldipine | 8.67e-06 | 78 | 140 | 6 | CID000004499 | |
| Drug | nifedipine | CACNA1A GRM4 GRM8 RYR2 ITPR1 ADRB2 TRPM3 SCD PKD1 UCK2 CACNA1I CACNA1G | 1.02e-05 | 415 | 140 | 12 | CID000004485 |
| Drug | Calcium | CACNA1A RALGDS GRIA1 RYR2 ITPR1 ADRB2 GCLC PKD1 ABCB11 CACNA1I CACNA1G SLC23A2 HRH3 | 1.16e-05 | 493 | 140 | 13 | ctd:D002118 |
| Drug | bepridil | 1.31e-05 | 126 | 140 | 7 | CID000002351 | |
| Drug | pimozide | 1.38e-05 | 127 | 140 | 7 | CID000016362 | |
| Drug | picrotoxin | 1.67e-05 | 181 | 140 | 8 | CID000031304 | |
| Drug | carbachol | CACNA1A GCNT2 GRM4 GRM8 RYR2 ITPR1 ADRB2 KCNC1 TRPM3 PKD1 CACNA1I CACNA1G EPDR1 SLC4A4 HRH3 | 2.28e-05 | 688 | 140 | 15 | CID000002551 |
| Drug | NSC759576 | 2.46e-05 | 191 | 140 | 8 | CID000003075 | |
| Drug | dihydropyridine | 2.65e-05 | 193 | 140 | 8 | CID000104822 | |
| Drug | manidipine | 2.69e-05 | 95 | 140 | 6 | CID000004008 | |
| Drug | EIPA | 2.69e-05 | 95 | 140 | 6 | CID000001795 | |
| Drug | Sparteine (-) [90-39-1]; Up 200; 17uM; MCF7; HT_HG-U133A | 2.85e-05 | 195 | 140 | 8 | 2790_UP | |
| Drug | isotetrandrine | 3.03e-05 | 97 | 140 | 6 | CID000005422 | |
| Drug | Evoxine [522-11-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 3.07e-05 | 197 | 140 | 8 | 6041_UP | |
| Drug | Bupropion hydrochloride [31677-93-7]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 3.18e-05 | 198 | 140 | 8 | 3180_UP | |
| Drug | nicardipine | 3.26e-05 | 145 | 140 | 7 | CID000004473 | |
| Drug | 3,5-dihydroxyphenylglycine | 3.41e-05 | 60 | 140 | 5 | CID000108001 | |
| Drug | isradipine | 3.60e-05 | 100 | 140 | 6 | CID000003784 | |
| Drug | methanethiosulfonate | 4.25e-05 | 103 | 140 | 6 | CID004188587 | |
| Drug | alpha-methyl-4-carboxyphenylglycine | 4.31e-05 | 32 | 140 | 4 | CID000001222 | |
| Drug | loperamide | 4.74e-05 | 105 | 140 | 6 | CID000003954 | |
| Drug | AC1L2VU3 | 4.81e-05 | 12 | 140 | 3 | CID000129572 | |
| Drug | pyraclofos | 5.00e-05 | 106 | 140 | 6 | CID000093460 | |
| Drug | Mibefradil | 6.22e-05 | 13 | 140 | 3 | ctd:D020748 | |
| Drug | tetralol | 6.22e-05 | 13 | 140 | 3 | CID000010747 | |
| Drug | L-Glutamic Acid | 6.25e-05 | 68 | 140 | 5 | DB00142 | |
| Drug | DCG-IV | 6.25e-05 | 68 | 140 | 5 | CID000115114 | |
| Drug | tetradotoxin | GABRD CACNA1A GRIA1 GRM4 GRM8 ADRB2 SCN5A CACNA1I CACNA1G EPDR1 HRH3 | 7.05e-05 | 428 | 140 | 11 | CID000020382 |
| Drug | felbamate | 7.18e-05 | 70 | 140 | 5 | CID000003331 | |
| Drug | gamma-Glu-Gly | 7.73e-05 | 37 | 140 | 4 | CID000100099 | |
| Drug | benzyloxyaspartate | 7.73e-05 | 37 | 140 | 4 | CID004133412 | |
| Drug | Hdel sequence | 7.73e-05 | 37 | 140 | 4 | CID000131113 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.60e-05 | 169 | 140 | 7 | 6064_DN | |
| Drug | AC1NBU2S | 8.67e-05 | 117 | 140 | 6 | CID004473765 | |
| Drug | Potassium Chloride | 8.67e-05 | 117 | 140 | 6 | ctd:D011189 | |
| Drug | lavendustin A | 9.26e-05 | 171 | 140 | 7 | CID000003894 | |
| Drug | sodium bicarbonate | 9.38e-05 | 74 | 140 | 5 | CID000010340 | |
| Drug | NiCl2 | 9.53e-05 | 119 | 140 | 6 | CID000024385 | |
| Drug | butamben | 9.81e-05 | 15 | 140 | 3 | CID000002482 | |
| Drug | 3-(1H-pyrrole-2-carboxylate | 9.99e-05 | 233 | 140 | 8 | CID000005114 | |
| Drug | AC1L1DXE | 1.00e-04 | 299 | 140 | 9 | CID000002548 | |
| Drug | papaverine | 1.11e-04 | 176 | 140 | 7 | CID000004680 | |
| Drug | 1,3-dioxoisoindoline-5-carboxamide | 1.12e-04 | 3 | 140 | 2 | CID010679219 | |
| Drug | 1-amino-2-phosphonomethylcyclopropanecarboxylic acid | 1.12e-04 | 3 | 140 | 2 | ctd:C523415 | |
| Drug | phenoxymethyl | 1.12e-04 | 3 | 140 | 2 | CID000134735 | |
| Drug | pentasulfane | 1.20e-04 | 16 | 140 | 3 | CID000448216 | |
| Drug | 8-bromoguanosine 3',5'-cyclic monophosphate | 1.26e-04 | 308 | 140 | 9 | CID000001915 | |
| Drug | mercury | CACNA1A PDS5B ABCC4 FTSJ1 HS1BP3 RYR2 ITPR1 GCLC PKD1 CACNA1I CACNA1G NR3C2 | 1.35e-04 | 542 | 140 | 12 | CID000023931 |
| Drug | NSC7524 | 1.37e-04 | 182 | 140 | 7 | CID000005657 | |
| Drug | Zonisamide | 1.45e-04 | 17 | 140 | 3 | DB00909 | |
| Drug | halothane | 1.45e-04 | 314 | 140 | 9 | CID000003562 | |
| Drug | Sodium | 1.71e-04 | 84 | 140 | 5 | ctd:D012964 | |
| Drug | ICI182,780; Down 200; 1uM; MCF7; HT_HG-U133A | 1.78e-04 | 190 | 140 | 7 | 5926_DN | |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 1.84e-04 | 191 | 140 | 7 | 5234_DN | |
| Drug | Proglumide [6620-60-6]; Up 200; 12uM; MCF7; HT_HG-U133A | 1.84e-04 | 191 | 140 | 7 | 3861_UP | |
| Drug | morphine hydrochloride | GABRD CACNA1A NPY5R GRIA1 GRM4 GRM8 ADRB2 ACKR3 ABCB11 CX3CR1 HRH3 | 1.96e-04 | 481 | 140 | 11 | CID000004253 |
| Drug | lanthanum | 1.98e-04 | 136 | 140 | 6 | CID000023926 | |
| Drug | AC1Q3ZOL | 2.01e-04 | 258 | 140 | 8 | CID000002376 | |
| Drug | dicyclohexyl phthalate | CUL4A ABCC4 ATR GRIA1 SUCNR1 SLC1A3 ITPR1 ADRB2 APH1A SLC19A1 SLCO2A1 ABCB11 PLEKHA1 SLC4A4 HRH3 | 2.02e-04 | 836 | 140 | 15 | ctd:C036042 |
| Drug | N-methyl-DL-aspartic acid | GABRD CACNA1A GRIA1 ADGRV1 GRM4 GRM8 SLC1A3 RYR2 ITPR1 ZACN PKD1 CACNA1I CACNA1G | 2.08e-04 | 655 | 140 | 13 | CID000004376 |
| Drug | Nalidixic acid sodium salt hydrate; Down 200; 14.6uM; HL60; HT_HG-U133A | 2.09e-04 | 195 | 140 | 7 | 2336_DN | |
| Drug | avermectin | 2.16e-04 | 48 | 140 | 4 | CID006450460 | |
| Drug | Terconazole [67915-31-5]; Down 200; 7.6uM; PC3; HT_HG-U133A | 2.22e-04 | 197 | 140 | 7 | 4583_DN | |
| Drug | Cephalexin monohydrate [23325-78-2]; Up 200; 11uM; MCF7; HT_HG-U133A | 2.22e-04 | 197 | 140 | 7 | 5250_UP | |
| Drug | Nitrarine dihydrochloride [20069-05-0]; Up 200; 10.6uM; PC3; HT_HG-U133A | 2.22e-04 | 197 | 140 | 7 | 3683_UP | |
| Drug | latanoprost | 2.23e-04 | 4 | 140 | 2 | ctd:C072042 | |
| Drug | 4-(1H-imidazol-4-ylmethyl)piperidine | 2.23e-04 | 4 | 140 | 2 | ctd:C085755 | |
| Drug | Betaxolol hydrochloride [63659-19-8]; Up 200; 11.6uM; PC3; HT_HG-U133A | 2.29e-04 | 198 | 140 | 7 | 4608_UP | |
| Drug | methylenecyclopropylglycine | 2.34e-04 | 49 | 140 | 4 | CID000441452 | |
| Drug | Galanthamine hydrobromide [1953-04-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 2.36e-04 | 199 | 140 | 7 | 2787_UP | |
| Drug | THIP Hydrochloride; Up 200; 22.6uM; MCF7; HT_HG-U133A | 2.36e-04 | 199 | 140 | 7 | 6511_UP | |
| Disease | Renal Tubular Acidosis, Type II | 2.02e-05 | 2 | 133 | 2 | C0268435 | |
| Disease | Inherited neuropathies | 3.18e-05 | 40 | 133 | 4 | C0598589 | |
| Disease | skin disease (implicated_via_orthology) | 6.03e-05 | 3 | 133 | 2 | DOID:37 (implicated_via_orthology) | |
| Disease | Distorted hearing | 6.03e-05 | 3 | 133 | 2 | C0877848 | |
| Disease | Arrhythmogenic Right Ventricular Dysplasia | 6.03e-05 | 3 | 133 | 2 | C0349788 | |
| Disease | Paracousis | 6.03e-05 | 3 | 133 | 2 | C0155536 | |
| Disease | Hearing problem | 6.03e-05 | 3 | 133 | 2 | C0260662 | |
| Disease | Dysacusis | 6.03e-05 | 3 | 133 | 2 | C1510450 | |
| Disease | Renal tubular acidosis | 1.20e-04 | 4 | 133 | 2 | C0001126 | |
| Disease | Alternating hemiplegia of childhood | 1.20e-04 | 4 | 133 | 2 | C0338488 | |
| Disease | renal tubular acidosis (is_implicated_in) | 1.20e-04 | 4 | 133 | 2 | DOID:14219 (is_implicated_in) | |
| Disease | Hereditary episodic ataxia | 1.20e-04 | 4 | 133 | 2 | cv:C1720189 | |
| Disease | response to tenofovir, creatinine clearance measurement | 1.57e-04 | 112 | 133 | 5 | EFO_0007934, EFO_0009279 | |
| Disease | Distal Renal Tubular Acidosis | 2.00e-04 | 5 | 133 | 2 | C1704380 | |
| Disease | Colorectal Neoplasms | 2.71e-04 | 277 | 133 | 7 | C0009404 | |
| Disease | childhood absence epilepsy (implicated_via_orthology) | 2.99e-04 | 6 | 133 | 2 | DOID:1825 (implicated_via_orthology) | |
| Disease | visual epilepsy (implicated_via_orthology) | 4.84e-04 | 34 | 133 | 3 | DOID:11832 (implicated_via_orthology) | |
| Disease | renal tubular acidosis (implicated_via_orthology) | 5.55e-04 | 8 | 133 | 2 | DOID:14219 (implicated_via_orthology) | |
| Disease | cystic fibrosis (implicated_via_orthology) | 7.11e-04 | 9 | 133 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 7.11e-04 | 9 | 133 | 2 | C3502809 | |
| Disease | threonate measurement | 8.86e-04 | 10 | 133 | 2 | EFO_0021032 | |
| Disease | lymphocyte percentage of leukocytes | DPAGT1 KDELR2 UBR2 XKR6 SBNO2 SLC4A1 ADRB2 SBNO1 NR3C2 CX3CR1 | 8.91e-04 | 665 | 133 | 10 | EFO_0007993 |
| Disease | mean reticulocyte volume | CUL4A DPAGT1 PDS5B ATR NOC3L SBNO2 SLC4A1 PIGC SLC19A1 SMOX IPO11 | 1.01e-03 | 799 | 133 | 11 | EFO_0010701 |
| Disease | Tachycardia, Ventricular | 1.08e-03 | 11 | 133 | 2 | C0042514 | |
| Disease | Long QT Syndrome | 1.08e-03 | 11 | 133 | 2 | C0023976 | |
| Disease | Autistic Disorder | 1.22e-03 | 261 | 133 | 6 | C0004352 | |
| Disease | Cardiomyopathy, Dilated | 1.34e-03 | 48 | 133 | 3 | C0007193 | |
| Disease | Colorectal Carcinoma | DPAGT1 RALGDS ABCC4 ABCA9 SLC19A1 ACKR3 SLCO2A1 ABCB11 NR3C2 PZP | 1.34e-03 | 702 | 133 | 10 | C0009402 |
| Disease | Anemia, Hemolytic, Acquired | 1.52e-03 | 13 | 133 | 2 | C0002879 | |
| Disease | Anemia, Hemolytic | 1.52e-03 | 13 | 133 | 2 | C0002878 | |
| Disease | Anemia, Microangiopathic | 1.52e-03 | 13 | 133 | 2 | C0002889 | |
| Disease | Microangiopathic hemolytic anemia | 1.52e-03 | 13 | 133 | 2 | C0221021 | |
| Disease | Mental Retardation, X-Linked Nonsyndromic | 1.52e-03 | 13 | 133 | 2 | C3501611 | |
| Disease | glucose measurement | 1.73e-03 | 380 | 133 | 7 | EFO_0004468 | |
| Disease | eating disorder, bipolar disorder | 1.77e-03 | 14 | 133 | 2 | EFO_0005203, MONDO_0004985 | |
| Disease | nervous system disorder | 1.78e-03 | 53 | 133 | 3 | C0027765 | |
| Disease | anemia (implicated_via_orthology) | 2.04e-03 | 15 | 133 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | lymphocyte count | DPAGT1 KDELR2 NOC3L BET1L PEX13 SLC43A3 GCNT2 SBNO2 SLC4A1 ITPR1 NPRL2 SBNO1 NR3C2 SMOX CX3CR1 | 2.53e-03 | 1464 | 133 | 15 | EFO_0004587 |
| Disease | cholangiocarcinoma (is_marker_for) | 3.05e-03 | 64 | 133 | 3 | DOID:4947 (is_marker_for) | |
| Disease | common carotid intimal medial thickness | 3.47e-03 | 67 | 133 | 3 | EFO_0004860 | |
| Disease | mean corpuscular hemoglobin concentration | CUL4A DPAGT1 PDS5B ATR BET1L SLC4A1 SLC19A1 ABCB11 CACNA1I SMOX SLC23A2 OR52A1 | 4.33e-03 | 1105 | 133 | 12 | EFO_0004528 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TIAVYSFFALSLVGR | 241 | Q8NFU0 | |
| ALRVFNIVFTSLFSL | 1596 | O00555 | |
| INYSVILSTRFFDIQ | 181 | Q9UM22 | |
| FERLQTVTNYFITSL | 61 | P07550 | |
| FLVRFISRYTQEIFS | 511 | P02730 | |
| ISRYTQEIFSFLISL | 516 | P02730 | |
| SSLVFLTYVISFIFR | 1116 | Q8IUA7 | |
| FLSAVSSNRYLIEFL | 86 | Q6PIY5 | |
| ATLFVVITFVRYNDT | 601 | Q14833 | |
| YATTARNSFIVLIIF | 261 | Q9UPC5 | |
| IVAFFILSYFLSRAR | 96 | Q9NYM9 | |
| QAFSVASRTLFYEIL | 5681 | Q8WXG9 | |
| YVFRVISAVVLSATA | 1016 | O95342 | |
| SIFFITVISIDRYLA | 116 | P49238 | |
| IYRFVRTLFSAAQLT | 171 | Q8ND76 | |
| AYTFVATSIIVLRFQ | 401 | O43246 | |
| LVNDDSIRIVFSYIF | 691 | Q96K78 | |
| IFILYTVRTKVFQSE | 716 | Q96K78 | |
| IYRFVRTLFSAAQLT | 191 | Q8N7R7 | |
| ISSLIVSYFLYRVVF | 536 | Q96F81 | |
| RAVVLEFQSTYLFTL | 921 | Q96F81 | |
| VLKTFAQARSYIFID | 1051 | P20742 | |
| NEIFTQLYRTLFSVI | 151 | Q9NTI5 | |
| FFLTLLSLRTYQSEV | 11 | Q99650 | |
| EFHSRYITTVIQRIF | 256 | Q9Y5P8 | |
| LSYLFIFAAIFRIRS | 216 | Q6IEU7 | |
| TRSFYRNVVGVLLVF | 81 | Q8N4Z0 | |
| SEATFYRLVQSFAVV | 151 | O60268 | |
| VAVAVFLLTFYVISQ | 11 | Q92520 | |
| ILFTLNFTITNLRYE | 13791 | Q8WXI7 | |
| SLQFVRLQLTFEEYT | 856 | P08235 | |
| VLVFYNDRASFQTLI | 1351 | Q14643 | |
| FRDVSSDVFYILQLA | 121 | P59045 | |
| SASLISALIFVFVYN | 11 | Q8N0V5 | |
| AAVSVLLQEVFRFAY | 76 | Q96BI3 | |
| LIQRSLEFSVSYVFT | 291 | Q9UI26 | |
| SFSRTVENIFYVSFI | 251 | Q8N140 | |
| SAITFSIRYQLVRLF | 391 | Q9H3H5 | |
| SQILFALVFTTRYLD | 36 | O43731 | |
| ILFLYSLIFSRTFER | 261 | A8MYZ0 | |
| FITLSYIQIFITVFR | 216 | Q9UKL2 | |
| IFVAFATVENYLLAS | 101 | Q8NH48 | |
| TRETCYFLNATILFL | 91 | Q8NEN9 | |
| EVFSKYLNFVSIILR | 211 | P51160 | |
| LLYRLIFSVSKQFQS | 316 | Q9H295 | |
| TLLTVLTQAKRYAFF | 1086 | Q9H0H0 | |
| FENSAYVVFVVLLTR | 436 | P48506 | |
| FAQSFDIYLTQILRV | 1766 | Q6KC79 | |
| LAQFTITSYRFTTEL | 211 | O14764 | |
| LTRQYFTVTNVIIFF | 226 | Q13651 | |
| YLVDLIAFLRSTFAV | 641 | Q9Y2D4 | |
| FLTVIISYIFIAFAS | 211 | Q8NH18 | |
| IATTFVIVTFVRYND | 596 | O00222 | |
| VLNFTALLIEYSFSR | 96 | Q7Z6Z7 | |
| YSILVALFHTILTFR | 151 | P0C7N5 | |
| YRTLVSLLLAFFVAS | 816 | Q9NXE4 | |
| ARSLLVFYVLVNSSQ | 781 | O15439 | |
| SVSIFSLVFTAVERY | 121 | Q99463 | |
| FFSYLGIRSSLVILQ | 686 | Q9UHC9 | |
| FTYHITVFSRNVQVS | 251 | P0C862 | |
| YQFLTAFSQLISRIC | 2136 | Q13535 | |
| LDTYILKNFVAFSRT | 171 | Q53GT1 | |
| YVAFASLFFILVSIT | 191 | P48547 | |
| YQILVVTRLAAFKSA | 41 | Q53T59 | |
| ERIFLTLSNYIFTAV | 1306 | O43497 | |
| VKSYLFRNAFVLLTV | 41 | P43003 | |
| VEALEFRTFLQIIYS | 106 | Q5XKL5 | |
| SIFLFLDRTYVLQNS | 151 | Q13619 | |
| RIFLTVSNYIFTAIF | 1201 | Q9P0X4 | |
| IRSLASVSYAAVDFF | 531 | Q9BQ39 | |
| FTYHITVFSRNVQVS | 251 | B2RNN3 | |
| SIIAVFYFLLARAIS | 226 | P25106 | |
| VTFTTFLLRCVDYNV | 226 | Q674R7 | |
| RLFLVNYTATIDVIY | 181 | Q9NZD2 | |
| TIFLCTYRAFTTTQQ | 141 | Q12967 | |
| SAFNIVLISYDRFLS | 121 | Q9Y5N1 | |
| VVRVIFSNISSIYQF | 146 | Q7Z6J4 | |
| SAQALSTIFYFRIFI | 46 | O96002 | |
| RAFALVSQAYTSIIA | 116 | Q99627 | |
| YNSTFRVVSVLTVLH | 226 | P01860 | |
| FNSTYRVVSVLTVLH | 176 | P01861 | |
| AQLRVLLAFYASTIV | 211 | Q9H583 | |
| RVANLIDSITFSVYQ | 3726 | Q9NYC9 | |
| TRDTAAIFLIFSIFI | 206 | Q96LL9 | |
| SQVLFAVVFTARYLD | 36 | P24390 | |
| FFTLIIISSYTANLA | 621 | P42261 | |
| VFINVPTVSFSRYLR | 416 | Q6UWW8 | |
| SLVFIFRVLVYLVTA | 26 | O95377 | |
| IALQVFFTARSSELY | 1706 | Q9Y238 | |
| YIARQLSFTGVTFKI | 531 | A3KN83 | |
| FAINFILLFYKVSTS | 4511 | Q92736 | |
| SQLLFALVFTTRYLD | 36 | P33947 | |
| LTALRYAFTVVANIT | 166 | Q6NUT3 | |
| SITFAREFQVLYSSL | 101 | Q9HBV1 | |
| EYNRAVTFKSIVAFL | 121 | Q14554 | |
| TISYTFRSVGTFNII | 1596 | P98161 | |
| ISYAFIVQAVLRIQS | 216 | Q9GZK3 | |
| HTETLNIVFVTYFRI | 491 | Q8WTT2 | |
| FFLRQLSVVELFYTT | 61 | Q8NGE3 | |
| SVIGFSYVQILRAVF | 211 | Q8NH55 | |
| AFIAASYILILRAVF | 216 | Q8NGK6 | |
| SIVLILSQRSLFKFY | 66 | Q8WU17 | |
| TVRTLSTFRNYTVQF | 51 | P82980 | |
| LFEIITSSRTFYVQA | 266 | Q9HB19 | |
| LRSLAVLFIVFTSYF | 226 | Q9NYV7 | |
| VISFFLLRAIYFVSV | 231 | P59539 | |
| FLISRYQFSFLTLVQ | 31 | Q5M8T2 | |
| RVFLLSAVFLAFVTT | 76 | P0DP42 | |
| SIDVFIAFYITTRLF | 346 | Q96LT4 | |
| LYVDNRFFTLTVTSL | 5181 | P0DPF2 | |
| LYVDNRFFTLTVTSL | 876 | B4DH59 | |
| SYRIAFTISLLLVQY | 206 | Q15761 | |
| VAEFSSVFLRLEYLQ | 256 | Q5SWL8 | |
| LSYLFIFAAIFRIRS | 216 | Q8NGP8 | |
| ITRAVLEQFLSFAKY | 566 | Q8NFP9 | |
| TIFRFSATNALYVLS | 101 | Q14524 | |
| YIARQLSFSGVTFRI | 476 | Q9Y2G9 | |
| KTTVARLIAIFFYTT | 96 | Q8NBI5 | |
| RLIAIFFYTTATLII | 101 | Q8NBI5 | |
| QYLTFILQVISRSFL | 391 | Q8NBI5 | |
| TKVFSAFALVRTIRY | 176 | Q92968 | |
| FISRELFDTVQVYII | 31 | Q8WTW4 | |
| RSYVGVTLLFAFSAV | 226 | Q92535 | |
| FVFNSRTAYAIPILV | 326 | Q969I6 | |
| FSIFYNNTLFLVVVI | 136 | Q9UNL2 | |
| IYFLDITVFQTRLQF | 701 | Q14028 | |
| VLFSIEVTSTYFAVR | 286 | P35523 | |
| NAILIIFVSYFGSRV | 81 | Q92959 | |
| RVISFALFASIFQLY | 371 | Q5GH73 | |
| FLLNRRFVEYVTFST | 496 | Q86Y38 | |
| TIFLVLLFSQYARNV | 276 | Q9UGH3 | |
| FSNFSIITTALLFRI | 126 | Q9BS91 | |
| FTYTRTQAQHLFIIL | 426 | Q9HCF6 | |
| NYISLAFLTFSVVLA | 186 | P41440 | |
| TVSLGVLKRQYTSFF | 331 | Q9NWM0 | |
| FTIAARVITFALFAS | 381 | Q5GH76 | |
| RVITFALFASVFQLY | 386 | Q5GH76 | |
| VFVATFLRYAVVLNA | 246 | O00767 | |
| VVILSQDSFYRVLTS | 56 | Q9BZX2 | |
| VFTAYDVFRVSLITS | 126 | P49638 | |
| VVINSFYIVTRPLAF | 271 | Q9BXA5 | |
| RDVTLLYSQLQVFFS | 161 | Q9UET6 | |
| VFVSNVFNVDILRYT | 66 | Q401N2 | |
| FTVTRLSAYQVTNLV | 96 | O00526 | |
| LILVATDASFLVQYF | 566 | Q9Y6R1 | |
| NLFEIVTTSRTFYVQ | 256 | Q9HB21 | |
| QYSRAFFLISVFTIL | 116 | A6NGA9 | |
| DVIARTYNIFAITFR | 186 | Q8IWV8 | |
| QRLVFLAAFVVYLET | 96 | Q15631 | |
| FVIQNAVFTLAYLVE | 2226 | Q9P2D8 | |
| YVAFASLFFILISIT | 291 | Q14003 | |
| HSQFTYFQVLRVVRL | 471 | Q8IZF0 |